Walter M - Search Results

1

LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.

Sáenz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D, Camaño P, Urtasun M, Vílchez J, Gutiérrez-Rivas E, Emparanza J, Merlini L, Paisán C, Goicoechea M, Blázquez L, Eymard B, Lochmuller H, Walter M, Bonnemann C, Figarella-Branger D, Kaplan JC, Urtizberea JA, Martí-Massó JF, López de Munain A. Sáenz A, et al. Among authors: walter m. Brain. 2005 Apr;128(Pt 4):732-42. doi: 10.1093/brain/awh408. Epub 2005 Feb 2. Brain. 2005. PMID: 15689361

2

High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study.

Walter MC, Lochmüller H, Toepfer M, Schlotter B, Reilich P, Schröder M, Müller-Felber W, Pongratz D. Walter MC, et al. J Neurol. 2000 Jan;247(1):22-8. doi: 10.1007/s004150050005. J Neurol. 2000. PMID: 10701893 Clinical Trial.

3

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.

Walter MC, Lochmüller H, Reilich P, Klopstock T, Huber R, Hartard M, Hennig M, Pongratz D, Müller-Felber W. Walter MC, et al. Neurology. 2000 May 9;54(9):1848-50. doi: 10.1212/wnl.54.9.1848. Neurology. 2000. PMID: 10802796 Clinical Trial.

4

Novel approaches to treat muscular dystrophies.

Walter MC, Lochmüller H. Walter MC, et al. Expert Opin Investig Drugs. 2001 Apr;10(4):695-707. doi: 10.1517/13543784.10.4.695. Expert Opin Investig Drugs. 2001. PMID: 11281819 Review.

5

Prion codon 129 homozygosity and sporadic inclusion body myositis.

Lampe J, Gossrau G, Reichmann H, Walter MC, Mendel B, Lochmüller H. Lampe J, et al. Among authors: walter mc. Neurology. 2001 Jul 24;57(2):368. doi: 10.1212/wnl.57.2.368. Neurology. 2001. PMID: 11468340 No abstract available.

6

Genetic identity of Marinesco-Sjögren/myoglobinuria and CCFDN syndromes.

Merlini L, Gooding R, Lochmüller H, Müller-Felber W, Walter MC, Angelicheva D, Talim B, Hallmayer J, Kalaydjieva L. Merlini L, et al. Among authors: walter mc. Neurology. 2002 Jan 22;58(2):231-6. doi: 10.1212/wnl.58.2.231. Neurology. 2002. PMID: 11805249

7

Variable reduction of caveolin-3 in patients with LGMD2B/MM.

Walter MC, Braun C, Vorgerd M, Poppe M, Thirion C, Schmidt C, Schreiber H, Knirsch UI, Brummer D, Müller-Felber W, Pongratz D, Müller-Höcker J, Huebner A, Lochmüller H. Walter MC, et al. J Neurol. 2003 Dec;250(12):1431-8. doi: 10.1007/s00415-003-0234-x. J Neurol. 2003. PMID: 14673575

8

Homozygosity for CCTG mutation in myotonic dystrophy type 2.

Schoser BG, Kress W, Walter MC, Halliger-Keller B, Lochmüller H, Ricker K. Schoser BG, et al. Brain. 2004 Aug;127(Pt 8):1868-77. doi: 10.1093/brain/awh210. Epub 2004 Jul 1. Brain. 2004. PMID: 15231584

9

Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood.

Walter MC, Dekomien G, Schlotter-Weigel B, Reilich P, Pongratz D, Müller-Felber W, Epplen JT, Huebner A, Lochmüller H. Walter MC, et al. Acta Myol. 2004 May;23(1):1-5. Acta Myol. 2004. PMID: 15298081

10

Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

Fischer D, Walter MC, Kesper K, Petersen JA, Aurino S, Nigro V, Kubisch C, Meindl T, Lochmüller H, Wilhelm K, Urbach H, Schröder R. Fischer D, et al. J Neurol. 2005 May;252(5):538-47. doi: 10.1007/s00415-005-0684-4. Epub 2005 Feb 23. J Neurol. 2005. PMID: 15726252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,801 results

Search Page